Announcements Trials
Browse Landscape

Phase

Phase 1 11Phase 2 9Phase 1/2 5Phase NA 2Phase EARLY_PHASE1 2

Status

Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 4Gastrointestinal 3Tumor-Agnostic 2Thoracic 2Sarcoma 2Breast 2Gynecologic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Sarcoma 35Glioblastoma 10Breast Neoplasms 9Gliosarcoma 8Osteosarcoma 7Melanoma 7Bone Neoplasms 7Stomach Neoplasms 6Pancreatic Neoplasms 6Ovarian Neoplasms 6Lung Neoplasms 6Head and Neck Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma, Alveolar Soft Part 4Colorectal Neoplasms 4Colonic Neoplasms 4Brain Neoplasms 4Rectal Neoplasms 3Oligodendroglioma 3Neoplasms 3Lymphoma 3Liver Neoplasms 3Gastrointestinal Neoplasms 3Desmoplastic Small Round Cell Tumor 3Dendritic Cell Sarcoma, Interdigitating 3Astrocytoma 3Small Cell Lung Carcinoma 2Sarcoma, Synovial 2Sarcoma, Kaposi 2Rhabdomyosarcoma 2

Interventions

Oncolytic Virotherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma × Sarcoma × Clear all
NCT05961111 2023-07-27

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Recruiting
20 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Sarcoma

NCT05860374 2023-05-16

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Unknown
20 enrolled
BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Carcinoma, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡